Your browser doesn't support javascript.
loading
Glutathione-dependent depalmitoylation of phospholemman by peroxiredoxin 6.
Howie, Jacqueline; Tulloch, Lindsay B; Brown, Elaine; Reilly, Louise; Ashford, Fiona B; Kennedy, Jennifer; Wypijewski, Krzysztof J; Aughton, Karen L; Mak, Jason K C; Shattock, Michael J; Fraser, Niall J; Fuller, William.
Affiliation
  • Howie J; School of Cardiovascular and Metabolic Health, University of Glasgow, Glasgow, UK; Division of Cellular and Systems Medicine, School of Medicine, University of Dundee, Dundee, UK.
  • Tulloch LB; Division of Cellular and Systems Medicine, School of Medicine, University of Dundee, Dundee, UK.
  • Brown E; School of Cardiovascular and Metabolic Health, University of Glasgow, Glasgow, UK.
  • Reilly L; Division of Cellular and Systems Medicine, School of Medicine, University of Dundee, Dundee, UK.
  • Ashford FB; Division of Cellular and Systems Medicine, School of Medicine, University of Dundee, Dundee, UK.
  • Kennedy J; School of Cardiovascular and Metabolic Health, University of Glasgow, Glasgow, UK; Division of Cellular and Systems Medicine, School of Medicine, University of Dundee, Dundee, UK.
  • Wypijewski KJ; School of Cardiovascular and Metabolic Health, University of Glasgow, Glasgow, UK; Division of Cellular and Systems Medicine, School of Medicine, University of Dundee, Dundee, UK.
  • Aughton KL; School of Cardiovascular and Metabolic Medicine and Sciences, King's College London, London, UK.
  • Mak JKC; School of Cardiovascular and Metabolic Medicine and Sciences, King's College London, London, UK.
  • Shattock MJ; School of Cardiovascular and Metabolic Medicine and Sciences, King's College London, London, UK.
  • Fraser NJ; Division of Cellular and Systems Medicine, School of Medicine, University of Dundee, Dundee, UK. Electronic address: n.fraser@dundee.ac.uk.
  • Fuller W; School of Cardiovascular and Metabolic Health, University of Glasgow, Glasgow, UK. Electronic address: will.fuller@glasgow.ac.uk.
Cell Rep ; 43(2): 113679, 2024 Feb 27.
Article in En | MEDLINE | ID: mdl-38236777
ABSTRACT
Phospholemman (PLM) regulates the cardiac sodium pump PLM phosphorylation activates the pump whereas PLM palmitoylation inhibits its activity. Here, we show that the anti-oxidant protein peroxiredoxin 6 (Prdx6) interacts with and depalmitoylates PLM in a glutathione-dependent manner. Glutathione loading cells acutely reduce PLM palmitoylation; glutathione depletion significantly increases PLM palmitoylation. Prdx6 silencing abolishes these effects, suggesting that PLM can be depalmitoylated by reduced Prdx6. In vitro, only recombinant Prdx6, among several peroxiredoxin isoforms tested, removes palmitic acid from recombinant palmitoylated PLM. The broad-spectrum depalmitoylase inhibitor palmostatin B prevents Prdx6-dependent PLM depalmitoylation in cells and in vitro. Our data suggest that Prdx6 is a thioesterase that can depalmitoylate proteins by nucleophilic attack via its reactive thiol, linking PLM palmitoylation and hence sodium pump activity to cellular glutathione status. We show that protein depalmitoylation can occur via a catalytic cysteine in which substrate specificity is determined by a protein-protein interaction.
Subject(s)
Key words

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Phosphoproteins / Sodium-Potassium-Exchanging ATPase / Peroxiredoxin VI Language: En Journal: Cell Rep Year: 2024 Document type: Article Affiliation country: Reino Unido Country of publication: Estados Unidos

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Phosphoproteins / Sodium-Potassium-Exchanging ATPase / Peroxiredoxin VI Language: En Journal: Cell Rep Year: 2024 Document type: Article Affiliation country: Reino Unido Country of publication: Estados Unidos